👃 Lost your sense of smell during or after COVID?
#Delta4’s AI-driven approach uncovered a potential drug candidate for post-COVID olfactory dysfunction.
Explore how drug repurposing and AI help tackle complex challenges in Long COVID care:
🔍 delta4.ai/long-covid
#COVIDRecovery #LongCOVID
#Delta4’s AI-driven approach uncovered a potential drug candidate for post-COVID olfactory dysfunction.
Explore how drug repurposing and AI help tackle complex challenges in Long COVID care:
🔍 delta4.ai/long-covid
#COVIDRecovery #LongCOVID
May 26, 2025 at 8:24 AM
👃 Lost your sense of smell during or after COVID?
#Delta4’s AI-driven approach uncovered a potential drug candidate for post-COVID olfactory dysfunction.
Explore how drug repurposing and AI help tackle complex challenges in Long COVID care:
🔍 delta4.ai/long-covid
#COVIDRecovery #LongCOVID
#Delta4’s AI-driven approach uncovered a potential drug candidate for post-COVID olfactory dysfunction.
Explore how drug repurposing and AI help tackle complex challenges in Long COVID care:
🔍 delta4.ai/long-covid
#COVIDRecovery #LongCOVID
🚀 Our collaboration with Concept Life Sciences highlights new treatment avenues by targeting astrocytes.
Join us on Sept 30th to see how we combine neuroscience expertise with Delta4’s Hyper-C platform to identify novel targets in neurodegeneration!
📅 Register here: tinyurl.com/CNSwebinar25
Join us on Sept 30th to see how we combine neuroscience expertise with Delta4’s Hyper-C platform to identify novel targets in neurodegeneration!
📅 Register here: tinyurl.com/CNSwebinar25
September 19, 2025 at 9:23 AM
🚀 Our collaboration with Concept Life Sciences highlights new treatment avenues by targeting astrocytes.
Join us on Sept 30th to see how we combine neuroscience expertise with Delta4’s Hyper-C platform to identify novel targets in neurodegeneration!
📅 Register here: tinyurl.com/CNSwebinar25
Join us on Sept 30th to see how we combine neuroscience expertise with Delta4’s Hyper-C platform to identify novel targets in neurodegeneration!
📅 Register here: tinyurl.com/CNSwebinar25
✨Discover Delta4's roots and the journey from bioinformatics breakthroughs to AI drug discovery. Tune into our latest podcast for insights and innovations in drug development:
pharmaventures.com/how-is-ai-ch...
#drugdiscovery #delta4 #ai #innovationinpharma #fsgs #orphandisease
pharmaventures.com/how-is-ai-ch...
#drugdiscovery #delta4 #ai #innovationinpharma #fsgs #orphandisease
January 28, 2025 at 10:55 AM
✨Discover Delta4's roots and the journey from bioinformatics breakthroughs to AI drug discovery. Tune into our latest podcast for insights and innovations in drug development:
pharmaventures.com/how-is-ai-ch...
#drugdiscovery #delta4 #ai #innovationinpharma #fsgs #orphandisease
pharmaventures.com/how-is-ai-ch...
#drugdiscovery #delta4 #ai #innovationinpharma #fsgs #orphandisease
With Hyper-C, Delta4’s proprietary AI platform, we leverage big data to refine molecular models and match compounds to diseases faster and more effectively. 🧠✨
Hyper-C provides actionable insights and clear hypotheses—redefining what’s possible in drug discovery. 💊🌟
delta4.ai/hyper-c/
Hyper-C provides actionable insights and clear hypotheses—redefining what’s possible in drug discovery. 💊🌟
delta4.ai/hyper-c/
April 13, 2025 at 3:04 PM
With Hyper-C, Delta4’s proprietary AI platform, we leverage big data to refine molecular models and match compounds to diseases faster and more effectively. 🧠✨
Hyper-C provides actionable insights and clear hypotheses—redefining what’s possible in drug discovery. 💊🌟
delta4.ai/hyper-c/
Hyper-C provides actionable insights and clear hypotheses—redefining what’s possible in drug discovery. 💊🌟
delta4.ai/hyper-c/
Swapped our loft office for a Josefstadt seminar hotel 🔥 Full day of brainstorming, tackling challenges, and fueling Delta4’s next chapter together. #TeamDelta4 #InnovationInAction
November 24, 2025 at 12:35 PM
Swapped our loft office for a Josefstadt seminar hotel 🔥 Full day of brainstorming, tackling challenges, and fueling Delta4’s next chapter together. #TeamDelta4 #InnovationInAction
Delta4’s CEO, Kurt Herpel, will present on Delta4's AI-powered Hyper-C platform at the WHY Summit Pharma Partnering Conference in #Basel on April 1st / 2nd. Looking forward to forging meaningful alliances! Discover more here: buff.ly/fgxYet4
#Delta4 #PharmaPartnering
#Delta4 #PharmaPartnering
March 26, 2025 at 3:03 PM
Delta4’s CEO, Kurt Herpel, will present on Delta4's AI-powered Hyper-C platform at the WHY Summit Pharma Partnering Conference in #Basel on April 1st / 2nd. Looking forward to forging meaningful alliances! Discover more here: buff.ly/fgxYet4
#Delta4 #PharmaPartnering
#Delta4 #PharmaPartnering
#Delta4's Enrico presented his poster at the #YSA Symposium 2026 at the Medical University of Vienna. His work on systems-biological modeling of the #AKI-to-#CKD transition was selected for Session V (Regeneration & Transplantation) and sparked lively scientific discussion.
#TranslationalResearch
#TranslationalResearch
May 18, 2026 at 9:30 AM
#Delta4's Enrico presented his poster at the #YSA Symposium 2026 at the Medical University of Vienna. His work on systems-biological modeling of the #AKI-to-#CKD transition was selected for Session V (Regeneration & Transplantation) and sparked lively scientific discussion.
#TranslationalResearch
#TranslationalResearch
Take your drug development pipeline to the next level with Delta4’s AI-powered platform!
💡 Accelerate Efficiency & Speed
✅ Boost Success Rates
🔍 Ensure Transparency
🧬 Gain Valuable Biomarker Insights
Learn more here:
delta4.ai/development-...
#Delta4 #DrugDiscovery #DrugTarget #DrugRepositioning
💡 Accelerate Efficiency & Speed
✅ Boost Success Rates
🔍 Ensure Transparency
🧬 Gain Valuable Biomarker Insights
Learn more here:
delta4.ai/development-...
#Delta4 #DrugDiscovery #DrugTarget #DrugRepositioning
May 30, 2025 at 9:22 AM
Take your drug development pipeline to the next level with Delta4’s AI-powered platform!
💡 Accelerate Efficiency & Speed
✅ Boost Success Rates
🔍 Ensure Transparency
🧬 Gain Valuable Biomarker Insights
Learn more here:
delta4.ai/development-...
#Delta4 #DrugDiscovery #DrugTarget #DrugRepositioning
💡 Accelerate Efficiency & Speed
✅ Boost Success Rates
🔍 Ensure Transparency
🧬 Gain Valuable Biomarker Insights
Learn more here:
delta4.ai/development-...
#Delta4 #DrugDiscovery #DrugTarget #DrugRepositioning
🪢Seeing connections changes decisions. Our new Services page features an interactive map of Delta4’s expertise. Connecting the dots is our specialty. Now you can explore the many dimensions of drug and biomarker discovery at your own pace. 💡Learn more: delta4.ai/services #Delta4 #DrugDiscovery
March 9, 2026 at 11:15 AM
🪢Seeing connections changes decisions. Our new Services page features an interactive map of Delta4’s expertise. Connecting the dots is our specialty. Now you can explore the many dimensions of drug and biomarker discovery at your own pace. 💡Learn more: delta4.ai/services #Delta4 #DrugDiscovery
Delta4’s AI drug discovery engine is available directly on a global life science marketplace, making it easier for pharma and biotech teams to explore new indications and drug repositioning opportunities with Hyper‑C.
🔗 Discover more in a blog by Scientist.com: www.scientist.com/blog/acceler...
🔗 Discover more in a blog by Scientist.com: www.scientist.com/blog/acceler...
August 10, 2026 at 10:20 AM
Delta4’s AI drug discovery engine is available directly on a global life science marketplace, making it easier for pharma and biotech teams to explore new indications and drug repositioning opportunities with Hyper‑C.
🔗 Discover more in a blog by Scientist.com: www.scientist.com/blog/acceler...
🔗 Discover more in a blog by Scientist.com: www.scientist.com/blog/acceler...
✈️ Delta4's P. Perco & E. Bono are taking off to the @projectpicked.bsky.social annual meeting (May 13–15)!
🎤 Paul will speak on omics data integration in cardiorenal drug discovery.
🧬 Enrico presents on target ID for the AKI to CKD transition.
Looking forward to great science & discussions! 💊
🎤 Paul will speak on omics data integration in cardiorenal drug discovery.
🧬 Enrico presents on target ID for the AKI to CKD transition.
Looking forward to great science & discussions! 💊
May 12, 2025 at 7:27 AM
✈️ Delta4's P. Perco & E. Bono are taking off to the @projectpicked.bsky.social annual meeting (May 13–15)!
🎤 Paul will speak on omics data integration in cardiorenal drug discovery.
🧬 Enrico presents on target ID for the AKI to CKD transition.
Looking forward to great science & discussions! 💊
🎤 Paul will speak on omics data integration in cardiorenal drug discovery.
🧬 Enrico presents on target ID for the AKI to CKD transition.
Looking forward to great science & discussions! 💊
🎯Technology & platforms like Delta4's Hyper-C have revolutionized the identification of "hidden effects" in drugs, unlocking new opportunities to address untreated diseases.🔗 Tune in to the full discussion to explore how this dual approach is shaping the future of healthcare! https://buff.ly/4gn7Lds
February 10, 2025 at 1:15 PM
🎯Technology & platforms like Delta4's Hyper-C have revolutionized the identification of "hidden effects" in drugs, unlocking new opportunities to address untreated diseases.🔗 Tune in to the full discussion to explore how this dual approach is shaping the future of healthcare! https://buff.ly/4gn7Lds
WORLD #LIVER DAY: Liver safety and liver disease aren’t separate problems.
Cases like #Ontozry show risks still emerge post-approval, while PBC/PSC reflect immune-driven damage.
Different triggers—same system under stress.
Read more on #Delta4's work in #PBC/#PSC: delta4.ai/development-...
Cases like #Ontozry show risks still emerge post-approval, while PBC/PSC reflect immune-driven damage.
Different triggers—same system under stress.
Read more on #Delta4's work in #PBC/#PSC: delta4.ai/development-...
April 19, 2026 at 7:00 AM
WORLD #LIVER DAY: Liver safety and liver disease aren’t separate problems.
Cases like #Ontozry show risks still emerge post-approval, while PBC/PSC reflect immune-driven damage.
Different triggers—same system under stress.
Read more on #Delta4's work in #PBC/#PSC: delta4.ai/development-...
Cases like #Ontozry show risks still emerge post-approval, while PBC/PSC reflect immune-driven damage.
Different triggers—same system under stress.
Read more on #Delta4's work in #PBC/#PSC: delta4.ai/development-...
💛 Behind every scientific connection is an amazing team. Proud of Delta4’s brilliant minds who made 2025 a year of collaboration, discoveries & growth. 🌐 Here’s to 2026!
December 13, 2025 at 10:00 AM
💛 Behind every scientific connection is an amazing team. Proud of Delta4’s brilliant minds who made 2025 a year of collaboration, discoveries & growth. 🌐 Here’s to 2026!
Delta4’s use of data-driven insights in pharmaceutical design is compelling. AI can streamline discovery, but real-world validation across diverse cohorts remains key. Stay tuned for clinical proof beyond the patent buzz.
March 24, 2025 at 12:16 PM
Delta4’s use of data-driven insights in pharmaceutical design is compelling. AI can streamline discovery, but real-world validation across diverse cohorts remains key. Stay tuned for clinical proof beyond the patent buzz.
Robin of Sherlock! I loved Delta4's games, but this one split the world into 3 parts on the cassette IIRC - it used save trickery so you could wander between them. But no matter how many times I got the tape replaced when I bought it, I could never get part 3 to load😮💨
November 10, 2025 at 9:25 PM
Robin of Sherlock! I loved Delta4's games, but this one split the world into 3 parts on the cassette IIRC - it used save trickery so you could wander between them. But no matter how many times I got the tape replaced when I bought it, I could never get part 3 to load😮💨
Finding the right #compounds for the right #diseases is a key challenge in #DrugRepositioning. Delta4’s Hyper-C platform starts with disease biology to identify promising therapeutic opportunities and provides mechanistic rationales to support development decisions.
Read more: delta4.ai/services/
Read more: delta4.ai/services/
August 4, 2026 at 11:35 AM
Finding the right #compounds for the right #diseases is a key challenge in #DrugRepositioning. Delta4’s Hyper-C platform starts with disease biology to identify promising therapeutic opportunities and provides mechanistic rationales to support development decisions.
Read more: delta4.ai/services/
Read more: delta4.ai/services/
Feed: "131 Off-Road"
By: Justin Nguyen on Monday, July 20, 2026
By: Justin Nguyen on Monday, July 20, 2026
Delta4x4 Racing rebrands to Delta Gelandesport
delta4×4’s racing division, which competes in the Dakar Classic, has rebranded from delta4×4 Racing to DELTA Geländesport.
131offroad.com
July 21, 2026 at 4:29 AM
Feed: "131 Off-Road"
By: Justin Nguyen on Monday, July 20, 2026
By: Justin Nguyen on Monday, July 20, 2026
delta4×4's racing division, which competes in the Dakar Classic, has rebranded from delta4×4 Racing to DELTA Geländesport.
131offroad.com/2026/07/20/d...
#Dakar2027 #DakarClassic
131offroad.com/2026/07/20/d...
#Dakar2027 #DakarClassic
Delta4x4 Racing rebrands to Delta Gelandesport
delta4×4’s racing division, which competes in the Dakar Classic, has rebranded from delta4×4 Racing to DELTA Geländesport.
131offroad.com
July 20, 2026 at 9:31 PM
delta4×4's racing division, which competes in the Dakar Classic, has rebranded from delta4×4 Racing to DELTA Geländesport.
131offroad.com/2026/07/20/d...
#Dakar2027 #DakarClassic
131offroad.com/2026/07/20/d...
#Dakar2027 #DakarClassic
Delta4 Secures European Patents for Two Compounds as Candidate Treatments ... - NEWS10 ABC - goo.gl/alerts/G3z5iu #GoogleAlerts
Delta4 Secures European Patents for Two Compounds as Candidate Treatments for Focal Segmental Glomerulosclerosis (FSGS)
Delta4 secures two EU patents for innovative FSGS treatments, advancing drug repurposing for rare kidney diseases. Delta4 is a digital drug discovery TechBio company founded in Vienna, Austria, specializing in AI-driven drug repurposing and indication expansion. Delta4 utilizes its proprietary Hyper-C platform to accelerate the identification of new therapeutic applications for existing compounds. AI and Computational Biology accelerate breakthrough therapy options: Delta4's Latest Milestone ...
goo.gl
February 11, 2025 at 2:46 AM
Delta4 Secures European Patents for Two Compounds as Candidate Treatments ... - NEWS10 ABC - goo.gl/alerts/G3z5iu #GoogleAlerts